Related Experiment Video
Updated: Feb 11, 2026

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
Published on: July 29, 2014
Complex formation between the vasopressin 1b receptor, β-arrestin-2, and the μ-opioid receptor underlies morphine
Taka-Aki Koshimizu1, Kenji Honda2, Sachi Nagaoka-Uozumi2
1Department of Pharmacology, Division of Molecular Pharmacology, Jichi Medical University, Shimotsuke, Tochigi, Japan. t_koshi@jichi.ac.jp.
Abstract:
Chronic morphine exposure upregulates adenylate cyclase signaling and reduces analgesic efficacy, a condition known as opioid tolerance. Nonopioid neurotransmitters can enhance morphine tolerance, but the mechanism for this is poorly understood. We show that morphine tolerance was delayed in mice lacking vasopressin 1b receptors (V1bRs) or after administration of V1bR antagonist into the rostral ventromedial medulla, where transcripts for V1bRs and μ-opioid receptors are co-localized. Vasopressin increased morphine-binding affinity in cells expressing both V1bR and μ-opioid receptors. Complex formation among V1bR, β-arrestin-2, and μ-opioid receptor resulted in vasopressin-mediated upregulation of ERK phosphorylation and adenylate cyclase sensitization. A leucine-rich segment in the V1bR C-terminus was necessary for the association with β-arrestin-2. Deletion of this leucine-rich segment increased morphine analgesia and reduced vasopressin-mediated adenylate cyclase sensitization. These findings indicate that inhibition of μ-opioid-receptor-associated V1bR provides an approach for enhancing morphine analgesia without increasing analgesic tolerance.
Insights
Blocking vasopressin 1b receptors (V1bRs) delays morphine tolerance by preventing receptor complex formation. This approach enhances morphine analgesia without increasing tolerance, offering a new therapeutic strategy.
Area of Science:
- Neuroscience
- Pharmacology
- Molecular Biology
Background:
- Chronic morphine use leads to opioid tolerance, reducing pain relief.
- The mechanisms by which nonopioid neurotransmitters influence opioid tolerance are not fully understood.
Purpose of the Study:
- To investigate the role of vasopressin 1b receptors (V1bRs) in the development of morphine tolerance.
- To elucidate the molecular mechanisms underlying V1bR involvement in opioid tolerance.
Main Methods:
- Utilized knockout mice lacking V1bRs and pharmacological antagonism of V1bRs in the rostral ventromedial medulla.
- Examined V1bR and μ-opioid receptor (MOR) co-localization and interactions using cell-based assays.
- Investigated the role of β-arrestin-2 and ERK phosphorylation in vasopressin-mediated signaling.
Main Results:
- Morphine tolerance was delayed in V1bR-deficient mice and upon V1bR antagonist administration.
- Vasopressin enhanced morphine-binding affinity to cells co-expressing V1bR and MOR.
- V1bR, β-arrestin-2, and MOR complex formation mediated vasopressin-induced ERK phosphorylation and adenylate cyclase sensitization.
- A specific leucine-rich segment in V1bR was crucial for β-arrestin-2 association.
Conclusions:
- Inhibition of μ-opioid-receptor-associated V1bR is a viable strategy to enhance morphine analgesia.
- Targeting V1bR signaling can mitigate the development of analgesic tolerance.
- This research offers a novel therapeutic avenue for improving opioid pain management.
More Related Videos
13:45Real-time Imaging of Leukotriene B4 Mediated Cell Migration and BLT1 Interactions with β-arrestin
Published on: December 23, 2010
10:19High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
Published on: November 23, 2013
Related Concept Videos
Opioid Receptors: Overview
Opioid Analgesics: Morphine and Other Natural Cogeners
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Internal Receptors
Adrenergic Antagonists: ɑ and β-Receptor Blockers
Receptor-mediated Endocytosis